AiM Medical Robots Unveils MRI-Compatible Robot Prototype

August 22, 2022
AiM Medical Robotics, which is developing MRI-compatible intraoperative robotics for neurosurgery, has announced a prototype of its robotics platform, as well as funding from the Sontag Innovation Fund, one of the largest private funders of brain cancer research in the U.S. The new investment comes subsequent to the close of AiM’s seed financing round, which was announced in March 2022.
The Worcester, Mass.-based company’s robotic platform is currently focused on a MRI-compatible system that is precision-focused, portable, and able to be used with any diagnostic MRI scanner.
“The prototype is a testament to the progress that our company has made so far, bringing us closer to our goal of improving outcomes for patients undergoing neurosurgery and providing cost savings to hospitals by eliminating errors and reducing procedure times,” said Bob Cathcart, CEO of AiM. “The Sontag Foundation’s commitment to fund innovative advancements towards the treatment of brain tumors perfectly aligns with AiM’s core values, and we look forward to a fruitful collaboration.”
“Dr. Pilitsis, Prof. Fischer, and the AiM team are developing a groundbreaking and innovative MRI-compatible robotics platform that has the potential to impact the lives of patients across neurological disorders,” said Scott Davis, Ph.D., senior associate of the Sontag Innovation Fund. “We are encouraged by the team and this technology and hope the investment will attract additional external capital to improve the health status of brain cancer patients.”
For more details on AiM Medical Robotics, visit its website here.
Related video:
{vimeo}741973075{/vimeo}